159 related articles for article (PubMed ID: 16911116)
1. Lomustine for the treatment of gastrointestinal mast cell tumour in a dog.
Baldi A; Colloca E; Spugnini EP
J Small Anim Pract; 2006 Aug; 47(8):465-7. PubMed ID: 16911116
[TBL] [Abstract][Full Text] [Related]
2. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Taylor F; Gear R; Hoather T; Dobson J
J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
[TBL] [Abstract][Full Text] [Related]
4. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
[TBL] [Abstract][Full Text] [Related]
5. Treatment of canine mast cell tumors with CCNU (lomustine).
Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM
J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263
[TBL] [Abstract][Full Text] [Related]
6. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).
Lejeune A; Skorupski K; Frazier S; Vanhaezebrouck I; Rebhun RB; Reilly CM; Rodriguez CO
Vet Comp Oncol; 2015 Sep; 13(3):267-80. PubMed ID: 23721492
[TBL] [Abstract][Full Text] [Related]
7. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
8. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Heading KL; Brockley LK; Bennett PF
Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
[TBL] [Abstract][Full Text] [Related]
9. Multiple cutaneous histiocytomas treated with lomustine in a dog.
Maina E; Colombo S; Stefanello D
Vet Dermatol; 2014 Dec; 25(6):559-62, e98-9. PubMed ID: 24963782
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of a feline oral mast cell tumor.
Wright ZM; Chretin JD
J Feline Med Surg; 2006 Aug; 8(4):285-9. PubMed ID: 16616568
[TBL] [Abstract][Full Text] [Related]
11. Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases.
Cooper M; Tsai X; Bennett P
Vet Comp Oncol; 2009 Sep; 7(3):196-206. PubMed ID: 19691648
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
13. Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space-occupying lesions.
Van Meervenne S; Verhoeven PS; de Vos J; Gielen IM; Polis I; Van Ham LM
Vet Comp Oncol; 2014 Mar; 12(1):67-77. PubMed ID: 22738696
[TBL] [Abstract][Full Text] [Related]
14. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.
Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH
J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008
[TBL] [Abstract][Full Text] [Related]
15. Dose-escalating vinblastine for the treatment of canine mast cell tumour.
Vickery KR; Wilson H; Vail DM; Thamm DH
Vet Comp Oncol; 2008 Jun; 6(2):111-9. PubMed ID: 19178670
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of metronomic administration of lomustine in dogs with cancer.
Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
[TBL] [Abstract][Full Text] [Related]
17. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
Moirano SJ; Dewey CW; Wright KZ; Cohen PW
Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and outcome for dogs with mast cell tumors and bone marrow involvement.
Marconato L; Bettini G; Giacoboni C; Romanelli G; Cesari A; Zatelli A; Zini E
J Vet Intern Med; 2008; 22(4):1001-7. PubMed ID: 18564225
[TBL] [Abstract][Full Text] [Related]
19. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.
Laprais A; Olivry T
BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
